CAMP4 THERAPEUTICS Profitability Analysis

CAMP Stock  USD 4.91  1.16  30.93%   
Based on CAMP4 THERAPEUTICS's profitability indicators, CAMP4 THERAPEUTICS PORATION may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess CAMP4 THERAPEUTICS's ability to earn profits and add value for shareholders.
For CAMP4 THERAPEUTICS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CAMP4 THERAPEUTICS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CAMP4 THERAPEUTICS PORATION utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CAMP4 THERAPEUTICS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CAMP4 THERAPEUTICS PORATION over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CAMP4 THERAPEUTICS. If investors know CAMP4 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CAMP4 THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CAMP4 THERAPEUTICS is measured differently than its book value, which is the value of CAMP4 that is recorded on the company's balance sheet. Investors also form their own opinion of CAMP4 THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is CAMP4 THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CAMP4 THERAPEUTICS's market value can be influenced by many factors that don't directly affect CAMP4 THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CAMP4 THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if CAMP4 THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CAMP4 THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CAMP4 THERAPEUTICS Shares Outstanding vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CAMP4 THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare CAMP4 THERAPEUTICS value to that of its competitors to determine the firm's financial worth.
CAMP4 THERAPEUTICS PORATION is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about  0.18  of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for CAMP4 THERAPEUTICS PORATION is roughly  5.44 . Comparative valuation analysis is a catch-all technique that is used if you cannot value CAMP4 THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CAMP4 Current Valuation vs. Competition

CAMP4 THERAPEUTICS PORATION is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Information Technology industry is currently estimated at about 20.27 Billion. CAMP4 THERAPEUTICS maintains roughly 109.74 Million in current valuation contributing less than 1% to equities under Information Technology industry.

CAMP4 Shares Outstanding vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

CAMP4 THERAPEUTICS

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
109.74 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

CAMP4 THERAPEUTICS

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
20.16 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

CAMP4 Shares Outstanding Comparison

CAMP4 THERAPEUTICS is currently under evaluation in shares outstanding category among its peers.

CAMP4 THERAPEUTICS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CAMP4 THERAPEUTICS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CAMP4 THERAPEUTICS will eventually generate negative long term returns. The profitability progress is the general direction of CAMP4 THERAPEUTICS's change in net profit over the period of time. It can combine multiple indicators of CAMP4 THERAPEUTICS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. CalAmp Corp operates under Communication Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 887 people.

CAMP4 Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CAMP4 THERAPEUTICS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CAMP4 THERAPEUTICS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CAMP4 THERAPEUTICS's important profitability drivers and their relationship over time.

CAMP4 THERAPEUTICS Profitability Trends

CAMP4 THERAPEUTICS profitability trend refers to the progression of profit or loss within a business. An upward trend means that CAMP4 THERAPEUTICS's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is CAMP4 THERAPEUTICS's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in CAMP4 THERAPEUTICS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Use Investing Themes to Complement your CAMP4 THERAPEUTICS position

In addition to having CAMP4 THERAPEUTICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products
Pharmaceutical Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.